Helex

Helex is a biotechnology company focused on bringing new hope to people living with genetic kidney diseases. They harness cutting-edge science to develop innovative medicines and drug delivery methods that can make a meaningful difference for kidney health.

Core Products and Services

• Helex is developing targeted therapies designed specifically for chronic and inherited kidney conditions, with an emphasis on hard-to-treat diseases like Autosomal Dominant Polycystic Kidney Disease.

• The company uses a specialized, non-viral lipid nanoparticle system to deliver therapeutic molecules directly to kidney cells. This helps improve precision and reduce side effects.

• Helex offers a digital platform that supports gene therapy researchers. These tools help scientists design better gene editing guides and predict the outcomes of gene editing experiments, making the development process more efficient and reliable.

• Their laboratory services include experimental validation and advanced genetic analysis to ensure new gene therapies are both safe and effective.

• The team also creates custom gene editing solutions to address a variety of kidney-related genetic targets.

Business Model

• Helex works primarily with other biotech, pharmaceutical, and gene therapy companies, supplying them with advanced technology and expert support to accelerate drug development.

• The company licenses its digital tools and platforms to partners who use them to develop new therapies in-house.

• Helex also engages in research collaborations, offering its technology, platforms, and expertise to support the development of novel kidney-targeted therapies.

Revenue Streams

• Helex earns licensing fees from companies that use its digital platforms for designing and validating new therapies.

• The company brings in service revenue through hands-on laboratory work, including analysis and validation projects for clients.

• Additional income is generated through collaborative partnerships, with payments that may be tied to development milestones or royalties on successful therapies.

Through this blend of technology, services, and collaboration, Helex is working to shape the future of kidney care—one breakthrough at a time.